Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tudor Oprea

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nature Reviews. Drug Discovery|May 4, 2019
Novel drug targets in 2018Oleg Ursu, Meir Glick, Tudor Oprea
Journal of Medicinal Chemistry|December 28, 2002
Surface descriptors for protein-ligand affinity predictionIsmael Zamora, Tudor Oprea, Gabriele Cruciani, et al.
Molecular Pharmaceutics|January 17, 2008
hERG classification model based on a combination of support vector machine method and GRIND descriptorsQiyuan Li, Flemming Steen Jørgensen, Tudor Oprea, et al.
Current Opinion in Chemical Biology|August 4, 2004
Flow cytometry for high-throughput, high-content screeningBruce S Edwards, Tudor Oprea, Eric R Prossnitz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 20, 2022
Autophagy and Herpesvirus: A collaboration Contributing to Alzheimer's DiseaseAmir R Nafchi, Mona Esmaeili, Orrin Myers, et al.
Health Informatics Journal|November 19, 2016
Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical recordsRodrigo Vazquez Guillamet, Oleg Ursu, Gary Iwamoto, et al.
Biochimica Et Biophysica Acta|March 22, 2016
A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanismMichael Gabl, André Holdfeldt, Malene Winther, et al.
Biochemical Pharmacology|March 14, 2012
A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1Hülya Cevik-Aras, Christina Kalderén, Annika Jenmalm Jensen, et al.
Journal of Biomedical Informatics|January 30, 2017
Protein biomarker druggability profilingSubramani Mani, Daniel Cannon, Robin Ohls, et al.
Experimental Cell Research|July 21, 2015
P2Y2 receptor signaling in neutrophils is regulated from inside by a novel cytoskeleton-dependent mechanismMichael Gabl, Malene Winther, Amanda Welin, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nature Reviews. Drug Discovery|May 4, 2019
Novel drug targets in 2018Oleg Ursu, Meir Glick, Tudor Oprea
Journal of Medicinal Chemistry|December 28, 2002
Surface descriptors for protein-ligand affinity predictionIsmael Zamora, Tudor Oprea, Gabriele Cruciani, et al.
Molecular Pharmaceutics|January 17, 2008
hERG classification model based on a combination of support vector machine method and GRIND descriptorsQiyuan Li, Flemming Steen Jørgensen, Tudor Oprea, et al.
Current Opinion in Chemical Biology|August 4, 2004
Flow cytometry for high-throughput, high-content screeningBruce S Edwards, Tudor Oprea, Eric R Prossnitz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 20, 2022
Autophagy and Herpesvirus: A collaboration Contributing to Alzheimer's DiseaseAmir R Nafchi, Mona Esmaeili, Orrin Myers, et al.
Health Informatics Journal|November 19, 2016
Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical recordsRodrigo Vazquez Guillamet, Oleg Ursu, Gary Iwamoto, et al.
Biochimica Et Biophysica Acta|March 22, 2016
A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanismMichael Gabl, André Holdfeldt, Malene Winther, et al.
Biochemical Pharmacology|March 14, 2012
A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1Hülya Cevik-Aras, Christina Kalderén, Annika Jenmalm Jensen, et al.
Journal of Biomedical Informatics|January 30, 2017
Protein biomarker druggability profilingSubramani Mani, Daniel Cannon, Robin Ohls, et al.
Experimental Cell Research|July 21, 2015
P2Y2 receptor signaling in neutrophils is regulated from inside by a novel cytoskeleton-dependent mechanismMichael Gabl, Malene Winther, Amanda Welin, et al.
Pageof 2